Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ST-101 |
Synonyms | |
Therapy Description |
ST-101 is an inhibitor of the transcription factor CCAAT/enhancer-binding protein beta, which may lead to inhibition of cell proliferation and tumor growth (PMID: 36121385). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ST-101 | ST101|ST 101|C/EBP Beta Antagonist ST101 | ST-101 is an inhibitor of the transcription factor CCAAT/enhancer-binding protein beta, which may lead to inhibition of cell proliferation and tumor growth (PMID: 36121385). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04478279 | Phase Ib/II | ST-101 | A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors | Active, not recruiting | USA | GBR | 0 |